ArcBest Corporation (FRA:AQY)

Intra-Cellular Therapies Statistics

Total Valuation

ArcBest has a market cap or net worth of EUR 1.38 billion. The enterprise value is 1.69 billion.

Market Cap	1.38B
Enterprise Value	1.69B

Important Dates

The last earnings date was Wednesday, July 30, 2025.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	May 9, 2025

Share Statistics

Current Share Class	22.80M
Shares Outstanding	n/a
Shares Change (YoY)	-2.87%
Shares Change (QoQ)	-1.13%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	22.48M

Valuation Ratios

The trailing PE ratio is 10.27 and the forward PE ratio is 12.65.

PE Ratio	10.27
Forward PE	12.65
PS Ratio	0.40
PB Ratio	1.25
P/TBV Ratio	1.78
P/FCF Ratio	22.73
P/OCF Ratio	7.02
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.45, with an EV/FCF ratio of 27.73.

EV / Earnings	12.54
EV / Sales	0.48
EV / EBITDA	4.45
EV / EBIT	17.06
EV / FCF	27.73

Financial Position

The company has a current ratio of 0.96, with a Debt / Equity ratio of 0.38.

Current Ratio	0.96
Quick Ratio	0.85
Debt / Equity	0.38
Debt / EBITDA	1.47
Debt / FCF	6.87
Interest Coverage	12.36

Financial Efficiency

Return on equity (ROE) is 12.50% and return on invested capital (ROIC) is 4.66%.

Return on Equity (ROE)	12.50%
Return on Assets (ROA)	3.29%
Return on Invested Capital (ROIC)	4.66%
Return on Capital Employed (ROCE)	7.11%
Revenue Per Employee	246,576
Profits Per Employee	9,627
Employee Count	14,000
Asset Turnover	1.66
Inventory Turnover	n/a

Taxes

In the past 12 months, ArcBest has paid 47.70 million in taxes.

Income Tax	47.70M
Effective Tax Rate	26.14%

Stock Price Statistics

The stock price has decreased by -38.60% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-38.60%
50-Day Moving Average	63.24
200-Day Moving Average	77.68
Relative Strength Index (RSI)	40.52
Average Volume (20 Days)	80

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ArcBest had revenue of EUR 3.45 billion and earned 134.78 million in profits. Earnings per share was 5.77.

Revenue	3.45B
Gross Profit	295.33M
Operating Income	109.30M
Pretax Income	182.48M
Net Income	134.78M
EBITDA	242.88M
EBIT	109.30M
Earnings Per Share (EPS)	5.77

Balance Sheet

The company has 118.93 million in cash and 418.49 million in debt, giving a net cash position of -299.56 million.

Cash & Cash Equivalents	118.93M
Total Debt	418.49M
Net Cash	-299.56M
Net Cash Per Share	n/a
Equity (Book Value)	1.11B
Book Value Per Share	48.56
Working Capital	-19.78M

Cash Flow

In the last 12 months, operating cash flow was 197.34 million and capital expenditures -136.41 million, giving a free cash flow of 60.93 million.

Operating Cash Flow	197.34M
Capital Expenditures	-136.41M
Free Cash Flow	60.93M
FCF Per Share	n/a

Margins

Gross margin is 8.56%, with operating and profit margins of 3.17% and 3.90%.

Gross Margin	8.56%
Operating Margin	3.17%
Pretax Margin	5.29%
Profit Margin	3.90%
EBITDA Margin	7.04%
EBIT Margin	3.17%
FCF Margin	1.76%

Dividends & Yields

This stock pays an annual dividend of 0.45, which amounts to a dividend yield of 0.64%.

Dividend Per Share	0.45
Dividend Yield	0.64%
Dividend Growth (YoY)	0.30%
Years of Dividend Growth	3
Payout Ratio	7.07%
Buyback Yield	2.87%
Shareholder Yield	3.51%
Earnings Yield	9.73%
FCF Yield	4.40%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4